The AMDI Respiratory Panel tests for the 5 most probable viruses that cause respiratory tract infections since the pandemic, including influenza A and B, respiratory syncytial virus and SARS-CoV-2.



Changing The Discussion On Next Generation Point Of Care Testing

A compact, easy to use molecular point-of-care system that utilizes multiplexing capability specifically for CLIA-waived environments.

It can run up to 32 targets at a time on a single sample in <10 minutes using a disposable disc.

The AMDI Fast PCR system is designed to be:

Simple and intuitive sample to answer workflow that takes <10 minutes

<10 MINUTE SAMPLE TO ANSWER 32 PLEX RT-PCR


 

1 RT-PCR TEST. 5 TARGETS. <10 MINUTES

AMDI RESPIRATORY PANEL

AMDI is developing targeted syndromic panels for the point-of-care using both the AMDI HBH technology and the gold-standard lab-quality RT-PCR technique.

AMDI Respiratory Panel
Sample Type: Anterior Nasal Swab in 1-3 mL Viral Transport Media


 

The AMDI Respiratory Panel tests for the 5 most probable viruses that cause respiratory tract infections since the pandemic, including influenza A and B, respiratory syncytial virus and SARS-CoV-2.

 


 

AMDI HBH Technology

AMDI has patented HBH Technology that eliminates the lengthy sample prep process in many RT-PCR workflows:

  • 15 seconds
  • Optimized Reagents
  • Small Volumes (no dilutions needed)
  • Comparable Sensitivity to the Gold Standard

Targets Assayed Using Hyperbaric Heating Technology:
Virus (SARS-CoV-2, Flu A/B, RSV, etc.), Bacteria (Bacillus), Eukaryotes (S. cerevisiae, HeLa) and Fungus (Candida)